An analysis of children with typhoid fever admitted in 1991.
| dc.contributor.author | Deshmukh, C T | en_US |
| dc.contributor.author | Nadkarni, U B | en_US |
| dc.contributor.author | Karande, S C | en_US |
| dc.date.accessioned | 1994-10-01 | en_US |
| dc.date.accessioned | 2009-06-02T12:22:16Z | |
| dc.date.available | 1994-10-01 | en_US |
| dc.date.available | 2009-06-02T12:22:16Z | |
| dc.date.issued | 1994-10-01 | en_US |
| dc.description.abstract | In 28 children, with bacteriologically and/or serologically diagnosed typhoid fever treated at KEM Hospital, Bombay in 1991, initially one of the three recommended drugs (viz. chloramphenicol, amoxycillin or co-trimoxazole) was given for 7 days for defervescence to occur. In those who failed to respond, a second trial of therapy with one of the other two drugs was initiated, after omitting the first drug. A second failure of therapy was taken as an indication to use ciprofloxacin singly. Eventually, 18 (64.3%) cases responded to chloramphenicol or amoxycillin or co-trimoxazole. Ciprofloxacin was used in 19(35.7%) cases. the failure rate of treatment with chloramphenicol was 50%, with amoxycillin 71.4%, with co-trimoxazole 75% and 0% with ciprofloxacin. An analysis of the 28 cases revealed that apart from fever (in 100%), splenomegaly (in 82.1%) was the most important clinical pointer to diagnosis, along with absolute eosinopenia (in 71.4%). There were no major complications, except 2 cases with typhoid hepatitis who responded to choramphenicol and co-trimoxazole, respectively. Blood culture grew Salmonella typhi in 7 cases, of which 5 (72%) were multidrug resistant S. typhi. There were no characteristic clinical features to identify multi-drug resistant typhoid fever. | en_US |
| dc.description.affiliation | Dept. of Pediatrics, KEM Hospital, Parel, Bombay, Maharashtra. | en_US |
| dc.identifier.citation | Deshmukh CT, Nadkarni UB, Karande SC. An analysis of children with typhoid fever admitted in 1991. Journal of Postgraduate Medicine. 1994 Oct-Dec; 40(4): 204-7 | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/116861 | |
| dc.language.iso | eng | en_US |
| dc.source.uri | https://www.jpgmonline.com | en_US |
| dc.subject.mesh | Amoxicillin --therapeutic use | en_US |
| dc.subject.mesh | Anti-Infective Agents --therapeutic use | en_US |
| dc.subject.mesh | Child | en_US |
| dc.subject.mesh | Ciprofloxacin --therapeutic use | en_US |
| dc.subject.mesh | Humans | en_US |
| dc.subject.mesh | Penicillins --therapeutic use | en_US |
| dc.subject.mesh | Splenomegaly | en_US |
| dc.subject.mesh | Trimethoprim-Sulfamethoxazole Combination --therapeutic use | en_US |
| dc.subject.mesh | Typhoid Fever --diagnosis | en_US |
| dc.title | An analysis of children with typhoid fever admitted in 1991. | en_US |
| dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1